Verdence Capital Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2,521
Closed -$207K 696
2025
Q4
$207K Buy
+2,521
New +$196K 0.01% 617
2025
Q3
Sell
-3,563
Closed -$264K 716
2025
Q2
$264K Sell
3,563
-159
-4% -$11.1K 0.02% 583
2025
Q1
$300K Sell
3,722
-427
-10% -$36.7K 0.02% 527
2024
Q4
$324K Buy
4,149
+480
+13% +$40.8K 0.03% 486
2024
Q3
$344K Sell
3,669
-1,366
-27% -$115K 0.03% 479
2024
Q2
$392K Sell
5,035
-368
-7% -$30K 0.03% 390
2024
Q1
$491K Sell
5,403
-569
-10% -$47.3K 0.04% 350
2023
Q4
$462K Buy
5,972
+63
+1% +$4.41K 0.04% 350
2023
Q3
$402K Sell
5,909
-179
-3% -$13K 0.04% 364
2023
Q2
$495K Buy
6,088
+123
+2% +$9.81K 0.06% 317
2023
Q1
$489K Buy
+5,965
New +$426K 0.06% 313

Other funds holding GEHC

Verdence Capital Advisors's GEHC Position: Q1 2026 in Review

Verdence Capital Advisors sold out of GE HealthCare (GEHC) in Q1 2026, closing a stake of 2,521 shares — an estimated $207K sold.

Verdence Capital Advisors first reported a position in GEHC in Q1 2023 and held it in 11 quarters. The position peaked at $495K in Q2 2023. 1,264 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Verdence Capital Advisors reported no remaining GE HealthCare position as of Q1 2026 after selling out during the quarter.
  • Verdence Capital Advisors sold 2,521 GE HealthCare shares in Q1 2026, an estimated $207K.
  • Verdence Capital Advisors first reported a position in GE HealthCare in Q1 2023 and held it in 11 quarters.
  • Verdence Capital Advisors's GE HealthCare position peaked at $495K in Q2 2023.
  • 1,264 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Verdence Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.